Drugs / CT1194C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07068906 | Jul 2025 → Jun 2026 overdue | B-cell non-Hodgkin lymphoma | Institute of Hematology & Blood Diseases Hospital, China | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT1194C | “A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma” NCT07068906 ↗ |
| Modality | Cell therapy | “CT1194C CAR-T Cell Therapy” NCT07068906 ↗ |